SCHEMBL6189048

SCHEMBL6189048

NC1CCN(CC=Cc2ccccc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.57
LMNA P02545 3/20 0.55
ALDH1A1 P00352 3/20 0.55
CYP3A4 P08684 2/20 0.55
HIF1A Q16665 2/20 0.55
HTR2A P28223 2/20 0.55
HTR2B P41595 2/20 0.55
SIGMAR1 Q99720 2/20 0.55
CYP1A2 P05177 2/20 0.55
CYP2D6 P10635 2/20 0.55
CYP2C9 P11712 2/20 0.55
MAPK1 P28482 2/20 0.55
GMNN O75496 1/20 0.55
ABCB11 O95342 1/20 0.55
CHRM2 P08172 1/20 0.55
CHRM4 P08173 1/20 0.55
HTR1A P08908 1/20 0.55
CHRM5 P08912 1/20 0.55
ADRA2A P08913 1/20 0.55
ADORA3 P0DMS8 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6189047 1.00 MCHR1 (0.57) MCHR1LMNAALDH1A1CYP3A4HIF1A
Hydrochloric Acid SCHEMBL9876512 0.97 MCHR1 (0.54) MCHR1LMNAALDH1A1CYP3A4HIF1A
SCHEMBL2579539 0.84 LMNA (0.72) LMNAALDH1A1CYP3A4HIF1AHTR2A
Hydrochloric Acid SCHEMBL25415886 0.83 HTR2A (0.55) MCHR1LMNAALDH1A1CYP3A4HIF1A
Hydrochloric Acid SCHEMBL25415884 0.83 HTR2A (0.55) MCHR1LMNAALDH1A1CYP3A4HIF1A
SCHEMBL613704 0.80 LTA4H (0.77) LMNAALDH1A1CYP3A4HIF1AHTR2A
SCHEMBL11036914 0.80 LTA4H (0.77) LMNAALDH1A1CYP3A4HIF1AHTR2A
SCHEMBL11389782 0.80 MCHR1 (0.61) MCHR1LMNAALDH1A1CHRM3SMN1; SMN2
SCHEMBL11389788 0.80 MCHR1 (0.61) MCHR1LMNAALDH1A1CHRM3SMN1; SMN2
SCHEMBL7304622 0.80 S1PR1 (0.67) MCHR1LMNAALDH1A1CHRM3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921821-B2 Antagonists of melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2005-07-26 US disclosed
EP-1534703-A2 ANTAGONISTS OF MELANIN CONCENTRATING HORMONE RECEPTOR ABBOTT LABORATORIES (US) 2005-06-01 EP disclosed
US-20040106645-A1 Antagonists of melanin concentrating hormone receptor MILLENNIUM PHARMACEUTICALS, INC. 2004-06-03 US disclosed
WO-2003106452-A2 ANTAGONISTS OF MELANIN CONCENTRATING HORMONE RECEPTOR MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-12-24 WO disclosed
EP-0111397-B1 ISOINDOLE DERIVATIVES, PREPARATION, AND USES Bristol-Myers Company (US) 1989-03-01 EP disclosed
US-4600758-A 5-SULFAMOYL-3-OXOISOINDOLES WITH ARLYPIPERIDINYL MOIETIES, DIURETICS, HYPOTENSIVES MEAD JOHNSON & COMPANY (US) 1986-07-15 US disclosed
US-4495194-A HYPOTENSIVE AGENTS; DIURETICS MEAD JOHNSON & COMPANY (US) 1985-01-22 US disclosed
US-4138492-A FOR TREATMENT OF GASTROINTESTINAL DISORDERS ANPHAR, S.A. (ES) 1979-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106645-A1 Antagonists of melanin concentrating hormone receptor MCHR1, MCHR2, MC1R MCHR1 1/4885LMNA 3781/4885ALDH1A1 660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.